Table 1

Baseline characteristics

TotalNOD (−)NOD (+)
n2,6852,58897
Candesartan*1,343 (50.0)1,305 (50.4)38 (39.2)
Prior antihypertensive treatment1,767 (65.8)1,702 (65.8)65 (67.0)
Age (years)63.7 ± 11.163.7 ± 11.264.9 ± 10.0
Male sex*1,471 (54.8)1,406 (54.3)65 (67.0)
BMI (kg/m2)*24.8 ± 3.624.1 ± 3.525.2 ± 3.4
SBP (mmHg)165.0 ± 14.8165.0 ± 14.8165.7 ± 16.1
DBP (mmHg)*94.3 ± 11.394.4 ± 11.390.5 ± 11.7
Pulse pressure (mmHg)*70.8 ± 15.870.6 ± 15.775.2 ± 18.4
Heart rate (beats/min)71.4 ± 10.971.4 ± 10.971.2 ± 9.5
Hyperlipidemia1,178 (43.9)1,136 (43.9)42 (43.3)
Smoking
    Never1,825 (68.0)1,766 (68.2)59 (60.8)
    Ever273 (10.2)261 (10.1)12 (12.4)
    Current587 (21.9)561 (21.7)26 (26.8)
Cerebrovascular disease344 (12.8)330 (12.8)14 (14.4)
LVH*1,139 (42.4)1,088 (42.0)51 (52.6)
Ischemic heart disease393 (14.6)381 (14.7)12 (12.3)
Proteinuria548 (20.4)530 (20.5)18 (18.6)
Renal dysfunction205 (7.6)196 (7.6)9 (9.3)
Peripheral vascular disease37 (1.4)35 (1.4)2 (2.1)
  • Data are n (%) or means ± SD.

  • *P < 0.05, NOD (−) vs. NOD (+).

  • †Stroke and transient ischemic attack. NOD, new-onset diabetes.